More on ALLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.0 Score)

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allogene Therapeutics (NQ:ALLO)
Delayed: 1.99 -0.01 (0.5%)
Prev. Close $2.00  
Open$1.96 
52 Wk High$ 
52 Wk Low$ 
Day High$2.00 
Day Low$1.93 
P/E N/A  
EPS$ 
Volume4,037,919 

Friends, Peers and Foes (?): ALCLS, CLLS, CHRS, ELVN, ONCY (more...)

Aug 31, 2026 08:30 AM Allogene Therapeutics Announces Participation in September Investor Conference
Aug 25, 2026 04:43 PM Form 4 Allogene Therapeutics, For: Aug 21 Filed by: Douglas Earl Martin
Aug 21, 2026 07:27 PM Form 144 Allogene Therapeutics, Filed by: Douglas Earl Martin
Aug 21, 2026 06:05 AM Form EFFECT Allogene Therapeutics,
Aug 17, 2026 04:15 AM Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
Aug 14, 2026 04:34 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Frazier Life Sciences Public Fund, L.P.
Aug 12, 2026 04:40 PM Allogene Therapeutics, Inc. (ALLO) Tops Q2 EPS by 4c
Aug 12, 2026 04:30 PM Allogene Therapeutics (ALLO) files $500M mixed shelf
Aug 12, 2026 04:23 PM Form S-3 Allogene Therapeutics,
Aug 12, 2026 04:18 PM Form 10-Q Allogene Therapeutics, For: Jun 30
View All Articles

Entities mentioned with ALLO

View All Entities